Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6123-6132
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6123
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6123
Antibody | Epitope | Antigen |
DF3 | Core peptide sequence (DTRPAPGS) in the extracellular tandem repeat | Poorly glycosylated MUC1 |
NCL-MUC-1-CORE | Core peptide sequence (GVTSAPDTRPAP) in the extracellular tandem repeat | Poorly glycosylated MUC1 |
MY.1E12 | O-linked Sialyl T1 antigen in the extracellular tandem repeat | Sialylated MUC1 |
NCL-MUC-1-GP | Carbohydrate in the extracellular tandem repeat | Sialylated MUC1 |
KL-6 | Core peptide sequence (PDTRPAP) with O-linked Sialyl T1 antigen in the extracellular tandem repeat | Sialylated MUC1 |
3'-sialylated, 6'-sulfated LNnT2 and 3'-sialylated, 6-sulfated T antigen3 | ||
HMFG-1 | Core peptide sequence (PDTR) in the extracellular tandem repeat | Highly-glycosylated MUC1 |
- Citation: Inagaki Y, Gao J, Song P, Kokudo N, Nakata M, Tang W. Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer. World J Gastroenterol 2014; 20(20): 6123-6132
- URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6123.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6123